syringaresinol has been researched along with Pneumonia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Cui, L; He, S; Hu, D; Wang, X; Yang, L; Zhang, L; Zhang, S; Zhao, J; Zhuo, Y | 1 |
1 other study(ies) available for syringaresinol and Pneumonia
Article | Year |
---|---|
Syringaresinol alleviates IgG immune complex induced acute lung injury via activating PPARĪ³ and suppressing pyroptosis.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Antigen-Antibody Complex; Caspase 1; Immunoglobulin G; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Pneumonia; PPAR gamma; Pyroptosis | 2023 |